Atlas Trials

Study of Sirolimus in IgG4-related Disease

Clinical trial NCT05746689 · NOT_YET_RECRUITING

Trial details

NCT number
NCT05746689
Sponsor
Peking University International Hospital
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
IgG4-related Disease
Start date
2023-03-01
Primary completion
2026-12-31
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.